![](https://www.Immune-System-Research.com/"wp-content/uploads"/2021/03/PF-05221304-is-an-Orally-Active-Liver-Directed-and-Dual-ACC1-and-ACC2-Inhibitor-2021-03-17.jpg)
The character of nonalcoholic fatty liver disease (NAFLD) is the accumulation of fat (in excess of 5%) within the hepatocytes.…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2021/01/GSK620-is-a-Potent-and-Orally-Active-pan-BET-BD2-Inhibitor-2020-01-08.jpg)
The therapeutic potential of extra terminal domain inhibitor (iBET) has increasing studies both in oncology and immunoinflammatory. Moreover, iBETs are…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2019/06/BA-53038B-is-a-HBV-Core-Protein-Allosteric-Modulator-CpAM-2019-07-01.jpg)
In our previous blogs, we have introduced two HBV inhibitors. Today, I’d like to describe another small molecule compound BA-53038B…